- Unity Biotechnology (NASDAQ:UBX) initiated with Overweight rating and $25 (92% upside) at Morgan Stanley. Initiated with Neutral rating and $17 price target at Goldman Sachs. Phase 1 study of OAK candidate UBX0101 to start this quarter. Shares up 3% premarket.
- Inspire Medical Systems (NYSE:INSP) initiated with Outperform rating at Wells Fargo. Initiated with Buy rating and $42 (35% upside) price target at Stifel. Initiated with Neutral rating and $25 price target at Goldman. Initiated with Buy rating and $40 price target at Guggenheim. Initiated with Buy rating and $32 price target at Citigroup.
- Quest Diagnostics (NYSE:DGX) upgraded to Overweight with a $120 (13% upside) at Morgan Stanley.
- Novartis (NYSE:NVS) downgraded to Hold at HSBC Securities.
Premarket analyst action - healthcare
Recommended For You
About UBX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
UBX | - | - |
Unity Biotechnology, Inc. |